Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2018 036 797.7 |
96 | EP file number | EAKZ | 18 77 6459.2 |
86 | WO file number | WAKZ | PCT/US2018/025366 |
97 | EP publication number | EPN | 3601363 |
87 | WO publication number | WPN | 2018183821 |
54 | Designation/title | TI | ALT-803 IN KOMBINATION MIT ANTI-CD38-ANTIKÖRPER FÜR KREBSTHERAPIEN |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 16/18 (2006.01), C07K 14/54 (2006.01), C07K 14/715 (2006.01), A61K 38/20 (2006.01), A61K 38/19 (2006.01), A61K 38/17 (2006.01), A61K 39/395 (2006.01), A61P 35/00 (2006.01), A61P 37/06 (2006.01) |
22 | DE application date | DAT | Mar 30, 2018 |
96 | EP application date | EAT | Mar 30, 2018 |
86 | WO application date | WAT | Mar 30, 2018 |
43 | Date of first publication | OT | Oct 4, 2018 |
| Date of publication of grant | PET | Jun 15, 2022 |
71/73 | Applicant/owner | INH | Altor BioScience Corporation, Miramar, FL, US |
72 | Inventor | IN | SHRESTHA, Niraj, Miramar,FL 33025, US; LIU, Bai, Cooper City, FL 33024, US; RHODE, Peter, Miramar ,FL 33025, US; WONG, Hing, C., Weston,FL 33332, US |
| Address for service | | AWA Sweden AB, 200 71 Malmö, SE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201762480339 P Mar 31, 2017
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201815937493 Mar 27, 2018
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003601363A1 Searchable text:
EP000003601363A1 Original document:
EP000003601363B1 Searchable text:
EP000003601363B1 Original document:
WO002018183821 Searchable text:
WO002018183821 |
43 | Date of first publication | EVT | Oct 4, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Feb 5, 2020 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 28, 2025 (Show all update days)(Hide all update days)- Mar 28, 2025
- Nov 27, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 19.06.2024: changed
- Oct 24, 2024
- Procedures: Opposition procedure, Patent maintained in full by EPO, 19.06.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 19.06.2024: new
- Procedures: Procedure relating to PCT application, Publication of PCT application, 04.10.2018: deleted
- Mar 29, 2024; Feb 29, 2024; Dec 14, 2023; Apr 7, 2023; Mar 30, 2023; Mar 23, 2023; Aug 23, 2022; Jul 6, 2022; May 26, 2022
- Historical data not available for this/these date(s)
- Feb 5, 2020
- Date of the first transfer into DPMAregister
|